Bioactive bone substitutes market seen hitting $3.16B by 2030

By AI, Created 5:11 PM UTC, May 18, 2026, /AGP/ – The Business Research Company projects the bioactive bone substitutes market will reach $3.16 billion by 2030, rising at a 9% annual pace. Growth is tied to more orthopedic and dental procedures, broader use of injectable and composite materials, and rising demand for bone regeneration therapies.

Why it matters: - Bioactive bone substitutes are becoming more important as orthopedic and dental conditions rise worldwide. - The market’s growth signals stronger demand for materials that help repair bone defects, support healing and reduce repeat surgeries. - The forecast points to expanding clinical use across both surgical and regenerative applications.

What happened: - The Business Research Company projected the global bioactive bone substitutes market will grow to $3.16 billion by 2030. - The market is expected to expand at a 9.0% compound annual growth rate through 2030. - The forecast was published May 14, 2026, in London. - The market is estimated to rise from $2.06 billion in 2025 to $2.24 billion in 2026, a CAGR of 8.7%.

The details: - Bioactive bone substitutes are synthetic or natural materials designed to replace or support damaged bone tissue while encouraging bone regeneration. - The materials interact with surrounding tissue by supporting cell attachment, growth and new bone formation. - The market’s recent growth has been driven by higher rates of orthopedic and dental disorders, wider use of synthetic hydroxyapatite and calcium phosphate, advances in biomaterials, more dental and orthopedic surgeries, and growing awareness of bone regeneration therapies. - Looking ahead, the company expects growth to be supported by more adoption of bioactive glass and polymer-based substitutes, more injectable and putty formulations, higher procedure volumes, more demand for nano hydroxyapatite composites, and collagen-ceramic composite matrices. - The report highlights a shift toward injectable and paste-like products, porous scaffolds, composite regeneration matrices, and broader dental and orthopedic applications. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region in the coming years. - The analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company also offered a free sample report and the full market report.

Between the lines: - Rising musculoskeletal disease rates are a key demand driver for bone substitute products. - UK data cited in the release showed 18.4% of people age 16 and older reported a long-term musculoskeletal condition in 2023, up from 17.6% in 2022. - Aging populations, higher obesity rates, sedentary lifestyles and sports injuries are contributing to the broader orthopedic burden. - The emphasis on injectable, paste-like and composite products suggests the market is moving toward easier handling and more adaptable surgical use.

What’s next: - Market growth is expected to continue as dental and orthopedic procedure volumes rise. - Adoption of newer biomaterial formats, especially bioactive glass, polymer-based substitutes and nano hydroxyapatite composites, is likely to shape the next phase of competition. - Regional momentum appears set to remain strongest in North America and fastest in Asia-Pacific.

The bottom line: - Bioactive bone substitutes are moving from niche biomaterials toward mainstream regenerative medicine tools, and the market outlook reflects that shift.